Hope银行集团 HOPE 深 沪
等待开盘 09-24 09:30:00 美东时间
10.79
0.000
0.00%
华盛通- 最 高11.041
- 今 开10.79
- 成交量 60.96万股
- 最 低 10.7605
- 昨 收 10.79
- 总市值 13.81亿
- 52周最高 13.975
- 市盈率 静 13.12
- 换手率 0.48%
- 52周最低 8.545
- 委 比 65.09%
- 总股本 1.28亿
- 历史最高 18.17
- 量 比 0.62
- 振 幅 2.60%
- 历史最低 -0.32
- 每 手 1
- 风险率 1.20%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多猎芯与物联网无线通信系统级服务企业华普微达成授权代理合作
（来源：猎芯网） 近日，电子元器件智慧供应链平台猎芯网与国家级专精特新“小巨人”企业深圳市华普微电子股份有限公司（以下简称“华普微”）正式达成授权合作。此次合作...
09-23 08:31
“HOPE血液全程管理论坛”在京召开
来源：环球网 9月12日，我国血液学领域首个"超越单一解决方案"的跨学科交流平台"HOPE血液全程管理论坛"在北京隆重举行。来自血液学领域、抗感染领域的权威专...
09-15 11:34
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics
HOPE Therapeutics announced the acquisition of Dura Medical, which operates two locations in Florida, providing precision psychiatry services including Ketamine Therapy and TMS. The acquisition, along with pending deals for Neurospa TMS and Cohen & Associates, aims to expand services to over 8 locations across Florida's West Coast and beyond. Dura Medical founder Stephen Durand, a US Army Veteran, will lead HOPE's Florida clinics. The company see...
09-08 12:17
Orchestra BioMed Reports Long-Term, Reversible Blood Pressure Benefits Of AVIM Therapy; Results Support Durable, Programmable Treatment For Uncontrolled Hypertension
Results from long-term follow up of patients treated with atrioventricular interval modulation ("AVIM") therapy show blood pressure-lowering effects are sustained for years after activation, reversible with no observed
09-05 05:01
Hope Bancorp announces retirement of honorary chairman
Hope Bancorp (NASDAQ:HOPE) announced on Friday the retirement of Honorary Chairman Steven Koh, effective December 31. After retirement, Koh plans to devote more time to philanthropy. More on Hope Banc...
08-30 00:45
Hope Bancorp Announces Steven S. Koh’s Retirement
Hope Bancorp ( ($HOPE) ) just unveiled an update. Hope Bancorp announced the re...
08-29 19:54
iECURE Announces It Will Present Additional Data From Its Ongoing OTC-Hope Clinical Trial Of ECUR-506 For Neonatal Onset Ornithine Transcarbamylase Deficiency At Two Upcoming Conferences In Kyoto, Japan
iECURE, Inc., a genome editing company focused on the development of variant-agnostic in vivo targeted gene insertion therapies for the treatment of liver disorders with significant unmet need, today announced that
08-25 20:09
强生&世界首富，160亿收购械企
8月7日，HistoSonics宣布完成一项控股权转让交易，其多数股权由K5 Global、Bezos Expeditions与Wellington Mana...
08-10 19:31
Hope Bancorp declares $0.14 dividend
Hope Bancorp (NASDAQ:HOPE) declared $0.14/share quarterly dividend, in line with previous. Forward yield 4.93% Payable Aug. 15; for shareholders of record Aug. 1; ex-div Aug. 1. See HOPE Dividend Scor...
07-22 19:06
Hope Bancorp Q2 Adj. EPS $0.19 Misses $0.21 Estimate, Sales $133.433M Miss $133.900M Estimate
Hope Bancorp (NASDAQ:HOPE) reported quarterly earnings of $0.19 per share which missed the analyst consensus estimate of $0.21 by 8.21 percent. This is a 13.64 percent decrease over earnings of $0.22 per share from the
07-22 19:03
